缅北禁地

Investors

Your browser does not support iframes.

缅北禁地 Release

October 8, 2024

鈥淯RECE庐 TABLETS鈥� (DOTINURAD) APPROVED IN THAILAND FOR GOUT AND HYPERURICEMIA
October 4, 2024

Eisai Announces Status and Completion of Acquisition of Own Shares
Acquisition of own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act
October 2, 2024

EISAI COMMENCES BUSINESS ACTIVITIES AT NEW PHARMA SALES SUBSIDIARY IN SAUDI ARABIA
October 1, 2024

Eisai Announces Status Relating to Acquisition of Own Shares
Acquisition of own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act
September 24, 2024

ROZEBALAMIN庐 FOR INJECTION 25 MG (MECOBALAMIN) APPROVED IN JAPAN FOR AMYOTROPHIC LATERAL SCLEROSIS

Latest Financial Reports

Consolidated Financial Report for First Quarter Financial Results for the Fiscal Year Ending March 31, 2025

August 2, 2024

Consolidated Financial Report
August 2, 2024

Reference Data
August 2, 2024

Financial Results Presentation

Latest Financial Reports

Financial Information

Latest Presentations

Electronic Public Notice

No corporate bonds have been issued at present.